SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Sartorius AG SOAGY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • DE • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Sartorius AG (SOAGY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $54.04. It has a SharesGrow Score of 36/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $3.4B, -6.2%/yr average growth. Net income is $149M, growing at -17.2%/yr. Net profit margin is 4.4% (thin). Gross margin is 46.3% (-6.3 pp trend).

Balance sheet: total debt is $4.5B against $2.7B equity (Debt-to-Equity (D/E) ratio 1.65, leveraged). Current ratio is 0.9 (tight liquidity). Debt-to-assets is 45.8%. Total assets: $9.7B.

Analyst outlook: 1 / 6 analysts rate SOAGY as buy (17%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 17/100 (Fail), Moat 58/100 (Partial), Future 20/100 (Fail), Income 30/100 (Fail).

SOAGY SharesGrow Score Overview

36/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

VALUE 15/100

Valuation — P/E, PEG, Forward PEG

GROWTH 15/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 17/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 58/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SOAGY

SOAGY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SOAGY: -6.2%/yr revenue is, -17.2%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SOAGY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SOAGY: Debt-to-Equity (D/E) ratio 1.65 (leveraged), Current ratio is 0.9 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SOAGY: Gross margin is 46.3% (-6.3 pp trend), $79B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 6 analysts rate SOAGY as buy (17%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SOAGY: Net profit margin is 4.4%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range38.235-62.15

Volume6.75K

Avg Volume (30D)13.45K

Market Cap$78.96B

Beta (1Y)1.45

Dividend Yield$0.0939

Share Statistics

EPS (TTM)0.43

Shares Outstanding$345.23M

IPO Date2020-10-13

Employees13,573

CEOMichael Grosse

Financial Highlights & Ratios

Revenue (TTM)$3.4B

Gross Profit$1.57B

EBITDA$1.03B

Net Income$148.79M

Operating Income$625.69M

Total Cash$541.17M

Total Debt$4.45B

Net Debt$3.91B

Total Assets$9.71B

Price / Earnings (P/E)125.7

Price / Sales (P/S)23.23

Analyst Forecast

Rating ConsensusHold

Analysts Covering6

Buy 17% Hold 83% Sell 0%

Company Info

CountryDE

ExchangeOther OTC

CurrencyUSD

ISINUS80385Q2084

Price Chart

SOAGY

Sartorius AG ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

38.24 52WK RANGE 62.15

People Also View

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

STAAR Surgical Company

Microbot Medical Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message